This study investigates the relationship between volatility and contract expiration for the case of Mexican interest rate futures. Specifically, it examines the hypothesis that the volatility of futures prices should increase as contracts approach expiration (the "maturity effect"). Using panel data techniques, the study assesses the differences in volatility patterns between contracts. The results show that although the maturity effect was sometimes present, the inverse effect prevails; volatility decreases as expiration approaches. On the basis of the premises of the negative covariance hypothesis, the study provides additional criteria that explain this behavior in terms of the term structure dynamics.
The relationship between monetary policy and the behaviour of financial markets is commonly examined to assess the effectiveness of the actions of central banks. Our study explores, for the case of Mexico, the reaction of short鈥恡erm interest rate futures to monetary policy announcements, and to what extent the change to the operational targeting of interest rates implemented by the central bank in 2004 led to changes in this reaction. The results show that in a market dominated by institutional investors trading solely for hedging purposes, the actions of the central bank are not fully incorporated into prices in advance. As a result, interest rate futures prices are adjusted on announcement dates. Furthermore, the change to an interest rate operational target modified the trading behaviour so that the changes in the volatility, volume and prices of the futures contracts on the announcement dates are now more evident.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.